The MoneyTree™ Report is a quarterly study of venture capital investment activity in the United States. As a collaboration between PricewaterhouseCoopers and the National Venture Capital Association based upon data from Thomson Reuters, it is the only industry-endorsed research of its kind.
For the most recent quarter's results including VC and company lists, as well as aggregate trend data dating back to 1995, visit our interactive MoneyTree Report site: pwcmoneytree.com
Third quarter Technology venture capital investment increased 23 percent year-over-year but fell 25 percent quarter-over-quarter.
Venture investment into Cleantech decreased by 72% from Q1 2015 compared to Q1 2014. Late stage investments were significantly down.
Q4 2014 Biotech Funding Surges
Biotechnology investments in the fourth quarter of 2014 reached the highest level recorded since the MoneyTreeTM data series was launched in 1995, breaking a record set just two quarters earlier. The biotech and medical devices industries both saw double-digit investment growth for the quarter and for the year.
With technology and innovation coming of age in many emerging countries, these fast-growing markets are important destinations for private equity. Together with our US MoneyTree™ Report, these reports will help you compare trends in various parts of the world and provide a truly global view of VC/PE investments. The global MoneyTree reports serve as a reliable source of current and recent trends in PE/VC funding for: Israel, India, Russia and China.